RUNX1 and leukemia: Mga deficiency in RUNX1::RUNX1T1 9 A expressing cells led to a significantly shortened leukemia latency with a median survival of 177 days for controls, 146 days for Mga(±) mice, and 132 days for Mga(−/−) mice (Fig. 5C).